Krsnaa Diagnostics Ltd
NSE:KRSNAA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
538.35
972.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd
Accounts Receivables
Krsnaa Diagnostics Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Accounts Receivables
₹1.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Accounts Receivables
₹129.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Accounts Receivables
₹434.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Accounts Receivables
₹901m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Accounts Receivables
₹149.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Accounts Receivables
₹1.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Krsnaa Diagnostics Ltd
Glance View
Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The company is headquartered in Pune, Maharashtra. The company went IPO on 2021-08-16. The firm is focused on providing radiology and pathology services for -radiation (X-rays), computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. The firm operates within India and has diagnostic centers all over India. The Company' studies in CT Scan include Peripheral Angio, Urography, Coronary Angio, Cisternography, CT Brain, CT Abdomen Triple Phase, CT HRCT Temporal Bone, CT Dentascan, CT Brain Angio, CT Perfusion, CT Renal Angio, CT Aortography and CT Pulmonary Angio. The Company’s services in color doppler include upper limb arterial doppler, upper limb venous doppler, lower limb arterial doppler, lower limb venous doppler, carotid doppler, hepatosplenic doppler, obstetric doppler and scrotal doppler.
See Also
What is Krsnaa Diagnostics Ltd's Accounts Receivables?
Accounts Receivables
1.9B
INR
Based on the financial report for Mar 31, 2024, Krsnaa Diagnostics Ltd's Accounts Receivables amounts to 1.9B INR.
What is Krsnaa Diagnostics Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
27%
Over the last year, the Accounts Receivables growth was 141%. The average annual Accounts Receivables growth rates for Krsnaa Diagnostics Ltd have been 37% over the past three years , 27% over the past five years .
You don't have any saved screeners yet
